Jose Manuel Ruiz Giardin

Dr. Jose Manuel Ruiz Giardin

Medicina Interna Infecciosas, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2019 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
JGJose Manuel Ruiz Giardin
Jose Manuel Ruiz Giardin
ICIciar Ochoa Chamorro
Iciar Ochoa Chamorro
LRLaura Velázquez Ríos
Laura Velázquez Ríos
JAJeronimo Jaqueti Aroca
Jeronimo Jaqueti Aroca
MAMaria Isabel García Arata
Maria Isabel García Arata
MSMarta Guerrero Santillán
Marta Guerrero Santillán
Background: The purposes of this study were to determine the incidence of central and peripheral venous catheter-related bacteraemias, the relationship between the suspected and final confirmed bacteraemia origins, and the differences in microbiological, epidemiological, clinical, and analytical characteristics between the groups, including evolution to death. Methods: This was a 7-year descriptive retrospective populational study of all bloodstream infections, comparing central (CB) and peripheral (PB) venous catheter-related bacteraemias in patients older than 15 years. Results: In all, 285 catheter-related bacteraemia patients, 220 with CBs (77.19%) and 65 with PBs (22.81%), were analysed among 1866 cases with bloodstream infections. The cumulative incidence per 1000 patients-day of hospital stay was 0.36 for CB and 0.106 for PB. In terms of the suspected origin, there was less accuracy in diagnosing catheter-related bloodstream infections (68. 2%) than those of other origins (78. 4%), p < 0.001. The accuracy was greater for PB (75%) than for CB (66. 2%), Coagulase-negative staphylococci were the most frequent microorganisms in both groups but occurred 1.57 times more frequently in CB (64.1%/40.6%) (p = 0.004), while Staphylococcus aureus (23. 4%/9.5%) (p = 0.02) and Enterobacteriae species (15.6%/6. 3%) (p = 0.003) were 2.5 times more frequent in PB. The CB patients stayed at the hospital for an average of 7.44 days longer than did the PB patients; more CB patients had active neoplasia (70. 4%/32.8%), more had surgery in the previous week (29. 2%/8. 3%), and fewer received adequate empirical treatment (53.9%/ 62.5%). Catheter was not removed in 8. 2% of CB and 3.7% of PB. On the other hand, the CB and PB patients had similar Pitt scores at blood extraction (median 0.89 versus 0.84 points, respectively; p = 0.8) and similar survival rates at hospital discharge (91.1% versus 90. 2%; p = 0.81). Conclusions: Central catheters were more frequent sources of bacteraemias than were peripheral catheters. There were important differences in the microbiological aetiology as well. PB patients received correct empirical antibiotic treatment more frequently and had a higher initial rate of correct determination of the suspected source of bacteraemia. Differences in the microbiological aetiology and empirical antibiotic treatment received, and probably catheter removal and time to catheter removal could explain why CB and PB patients had similar survival rates .

1 April 2016 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
AMA.I. Franco Moreno
A.I. Franco Moreno
MNM.J. García Navarro
M.J. García Navarro
JSJ. Ortiz Sánchez
J. Ortiz Sánchez
RDR.M. Martín Díaz
R.M. Martín Díaz
ECE. Madroñal Cerezo
E. Madroñal Cerezo
JGJose Manuel Ruiz Giardin
Jose Manuel Ruiz Giardin

24 July 2019 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
LHLuis Horrillo
Luis Horrillo
ACAlicia Castro
Alicia Castro
BMBelén Matía
Belén Matía
LMLaura Molina
Laura Molina
JGJesús García-Martínez
Jesús García-Martínez
JMJuan San Martín
Juan San Martín
An outbreak of leishmaniasis caused by Leishmania infantum was declared in the southwest of the Madrid region (Spain) in June 2009. This provided a unique opportunity to compare the management of visceral leishmaniasis (VL) in immunocompetent adults (IC-VL), patients with HIV (HIV-VL) and patients receiving immunosuppressants (IS-VL). A cohort of adults with VL, all admitted to the Hospital Universitario de Fuenlabrada between June 2009 and June 2018, were monitored in this observational study, recording their personal, epidemiological, analytical, diagnostic, treatment and outcome variables. The study population was made up of 111 patients with VL (10% HIV-VL, 14% IS-VL, 76% IC-VL). Seventy-one percent of the patients were male; the mean age was 45 years (55 years for the IS-VL patients, P = 0.017). Fifty-four percent of the IC-VL patients were of sub-Saharan origin (P = 0.001). Fever was experienced by 98% of the IC-VL patients vs 73% of the LV-HIV patients (P = 0.003). Plasma ferritin was > 1000 ng/ml in 77% of the IC-VL patients vs 17% of the LV-HIV patients (P = 0.007). Forty-two percent of patients fulfilled the criteria for haemophagocytic lymphohistiocytosis. RDT (rK39-ICT) serological analysis returned sensitivity and specificity values of 45% and 99%, respectively, and ELISA/iIFAT returned 96% and 89%, respectively, with no differences in this respect between patient groups. Fourteen (13.0%) patients with VL experienced treatment failure, eight of whom were in the IC-VL group. Treatment with < 21 mg/kg (total) liposomal amphotericin B (LAB) was associated with treatment failure in the IC-VL patients [P = 0.002 (OR: 14.7; 95% CI: 2.6–83.3)]. IS-VL was more common than HIV-VL; the lack of experience in dealing with IS-VL is a challenge that needs to be met. The clinical features of the patients in all groups were similar, although the HIV-VL patients experienced less fever and had lower plasma ferritin concentrations. RDT (rK39-ICT) analysis returned a good specificity value but a much poorer sensitivity value than reported in other scenarios. The patients with HIV-VL, IS-VL and IC-VL returned similar serological results. Current guidelines for treatment seem appropriate, but the doses of LAB required to treat patients with HIV-VL and IS-VL are poorly defined.

1 March 2014 in Emerging Infectious Diseases
Verified
Journal Article
Open access
GRGerardo Rojo-Marcos
Gerardo Rojo-Marcos
JRJose Miguel Rubio
Jose Miguel Rubio
GRGerman Ramirez-Olivencia
German Ramirez-Olivencia
SGSilvia García-Bujalance
Silvia García-Bujalance
RERosa Elcuaz-Romano
Rosa Elcuaz-Romano
JCJuan Cuadros-González
Juan Cuadros-González
Sequencing data from Plasmodium ovale genotypes co-circulating in multiple countries support the hypothesis that P. ovale curtisi and P. ovale wallikeri are 2 separate species. We conducted a multicenter, retrospective, comparative study in Spain of 21 patients who had imported P. ovale curtisi infections and 14 who had imported P. ovale wallikeri infections confirmed by PCR and gene sequencing during June 2005–December 2011. The only significant finding was more severe thrombocytopenia among patients with P. ovale wallikeri infection than among those with P. ovale curtisi infection (p = 0.031). However, we also found nonsignificant trends showing that patients with P. ovale wallikeri infection had shorter time from arrival in Spain to onset of symptoms, lower level of albumin, higher median maximum core temperature, and more markers of hemolysis than did those with P. ovale curtisi infection. Larger, prospective studies are needed to confirm these findings. <!-- link to audio presentation here --> <!--[if!IE]><!--> Download MP3 <!--><![endif]--><!--[if IE]> Download MP3 <![endif]--> Length: 1:27

1 December 2015 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
JGJose Manuel Ruiz Giardin
Jose Manuel Ruiz Giardin
RMRosa M. Martin-Díaz
Rosa M. Martin-Díaz
JJJerónimo Jaqueti-Aroca
Jerónimo Jaqueti-Aroca
IGIsabel Garcia-Arata
Isabel Garcia-Arata
JMJuan San Martín
Juan San Martín
MBMiguel Sáiz-Sánchez Buitrago
Miguel Sáiz-Sánchez Buitrago
The objective of this study was to predict the diagnosis of bacteraemia as a function of the time at which the automated BacT/Alert system continuously detects microorganism growth. A retrospective study of a database of 1334 patients with a positive blood culture between January 2011 and June 2013 was conducted. Together with the final blood culture results and the patient's history, growth was then analysed to assess whether it represented true bacteraemia or bacterial contamination. The earliest detection times of bacterial growth in each batch of blood cultures were analysed in a blinded fashion after classification. In total, 590 batches of blood cultures corresponded to true bacteraemia and 744 to bacterial contamination. In the bacteraemia group, the median growth time was 12.72 h (interquartile range (IQR) 10.08-17.58 h). In the contaminated blood culture group, the median growth time was 20.6h (IQR 17.04-32.16 h) (p<0.001). Analysis of the receiver operating characteristics (ROC) curve (area under the curve 0.80, 95% confidence interval 0.771-0.826) showed that 90% of the contaminants grew after 14.7h (sensitivity 90.5%, specificity 63.4%, positive predictive value (PPV) 65.9%, negative predictive value (NPV) 90.7%). Forty-five percent of the bacteraemia organisms grew in under 12h (sensitivity 45.3%, specificity 95%, PPV 87.8%, NPV 68.7%). Microorganisms such as Candida sp and Bacteroides sp presented median growth times significantly longer than those of the other microorganisms. The administration of antibiotics in the week prior to bacteraemia was found to delay the growth time of microorganisms (p<0.001). Knowing the time to detection of microorganism growth can help to distinguish between true bacteraemia and bacterial contamination, thus allowing more timely clinical decisions to be made, before definitive microorganism identification.

1 September 2020 in Clinical Immunology
Verified
Journal Article
Closed access
AMAlejandro Morales-Ortega
Alejandro Morales-Ortega
DBDavid Bernal-Bello
David Bernal-Bello
CLCristina Llarena-Barroso
Cristina Llarena-Barroso
BFBegoña Frutos-Pérez
Begoña Frutos-Pérez
MDMiguel Ángel Duarte-Millán
Miguel Ángel Duarte-Millán
JMJuan Víctor San Martín-López
Juan Víctor San Martín-López